Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)

OBJECTIVES: Patient experiences are critical when determining the acceptability of novel interventional pharmaceuticals. Here, we report the development and validation of a product acceptability questionnaire (SPRAY PAL) assessing feasibility, acceptability and tolerability of an intranasal Q-Griffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cash, Elizabeth, Deitz, Kailyn, Potts, Kevin L, Nabeta, Henry W, Zahin, Maryam, Rai, Shesh N, Dryden, Gerald W, Palmer, Kenneth E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503384/
https://www.ncbi.nlm.nih.gov/pubmed/37699630
http://dx.doi.org/10.1136/bmjopen-2023-073735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503384/
https://www.ncbi.nlm.nih.gov/pubmed/37699630
http://dx.doi.org/10.1136/bmjopen-2023-073735

Ejemplares similares